Ma Songjiang
SEC CIK 1985547 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | Pres, Dir | 2.81M | — | $1.56M | 39 | 2024-01-03 | 2025-05-27 |
Transactions 39
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2025-05-29 | 2025-05-27+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.23 | -2,558 | 2.81M | -0.1% | -$26.2K |
| MTI | 2025-05-27 | 2025-05-22+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.91 | -2,182 | 2.81M | -0.1% | -$23.8K |
| MTI | 2025-05-22 | 2025-05-20+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.04 | -4,000 | 2.81M | -0.1% | -$44.2K |
| MTI | 2025-05-20 | 2025-05-16+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.21 | -4,000 | 2.82M | -0.1% | -$44.8K |
| MTI | 2025-05-16 | 2025-05-14+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.69 | -2,020 | 2.82M | -0.1% | -$21.6K |
| MTI | 2025-05-14 | 2025-05-12+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.96 | -4,000 | 2.82M | -0.1% | -$43.9K |
| TI | 2025-03-25 | 2025-03-21 | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.00 | -174 | 2.82M | -0.0% | -$1,740 |
| MTI | 2025-03-21 | 2025-03-19+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.11 | -4,000 | 2.83M | -0.1% | -$40.4K |
| MTI | 2025-03-19 | 2025-03-17+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.89 | -2,242 | 2.83M | -0.1% | -$26.7K |
| MTI | 2025-03-17 | 2025-03-13+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.05 | -4,000 | 2.83M | -0.1% | -$48.2K |
| MTI | 2025-03-13 | 2025-03-11+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.57 | -4,000 | 2.84M | -0.1% | -$46.3K |
| MTI | 2025-03-11 | 2025-03-07+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.19 | -4,000 | 2.84M | -0.1% | -$40.8K |
| MTI | 2025-03-07 | 2025-03-05+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.89 | -4,000 | 2.85M | -0.1% | -$43.6K |
| MTI | 2025-03-05 | 2025-03-03+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.04 | -4,000 | 2.85M | -0.1% | -$44.2K |
| MTI | 2025-03-03 | 2025-02-27+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.37 | -4,000 | 2.85M | -0.1% | -$45.5K |
| MTI | 2025-02-27 | 2025-02-25+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.50 | -4,000 | 2.86M | -0.1% | -$46.0K |
| MTI | 2025-02-25 | 2025-02-21+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.30 | -4,000 | 2.86M | -0.1% | -$45.2K |
| MTI | 2025-02-21 | 2025-02-19+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.35 | -4,000 | 2.86M | -0.1% | -$49.4K |
| MTI | 2025-02-19 | 2025-02-14+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.21 | -4,000 | 2.87M | -0.1% | -$48.9K |
| MTI | 2025-02-14 | 2025-02-12+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.59 | -4,000 | 2.87M | -0.1% | -$46.4K |
| MTI | 2025-02-12 | 2025-02-10+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.72 | -3,878 | 2.88M | -0.1% | -$45.4K |
| MTI | 2025-02-11 | 2025-02-06+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.51 | -4,000 | 2.88M | -0.1% | -$50.0K |
| MTI | 2025-02-06 | 2025-02-04+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.01 | -4,000 | 2.88M | -0.1% | -$48.0K |
| MTI | 2025-02-04 | 2025-01-31+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.49 | -4,000 | 2.89M | -0.1% | -$46.0K |
| MTI | 2025-01-31 | 2025-01-29+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.40 | -4,000 | 2.89M | -0.1% | -$45.6K |
| MTI | 2025-01-29 | 2025-01-27+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.35 | -4,000 | 2.90M | -0.1% | -$45.4K |
| MTI | 2025-01-27 | 2025-01-23+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.69 | -4,000 | 2.90M | -0.1% | -$42.8K |
| MTI | 2025-01-24 | 2025-01-21+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.74 | -4,000 | 2.90M | -0.1% | -$43.0K |
| MTI | 2025-01-21 | 2025-01-16+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.71 | -4,000 | 2.91M | -0.1% | -$42.9K |
| MTI | 2025-01-16 | 2025-01-14+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.62 | -4,000 | 2.91M | -0.1% | -$42.5K |
| MTI | 2025-01-14 | 2025-01-10+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.02 | -1,113 | 2.92M | -0.0% | -$11.2K |
| ATI | 2025-01-10 | 2025-01-03 | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.85 | -833 | 2.92M | -0.0% | -$9,871 |
| MTI | 2025-01-08 | 2025-01-06+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.08 | -2,216 | 2.92M | -0.1% | -$22.3K |
| MTI | 2025-01-06 | 2024-01-03+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.89 | -4,000 | 2.92M | -0.1% | -$47.5K |
| MTI | 2025-01-02 | 2024-12-30+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.40 | -4,000 | 2.92M | -0.1% | -$49.6K |
| MTI | 2024-12-30 | 2024-12-26+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.64 | -4,000 | 2.93M | -0.1% | -$50.6K |
| MTI | 2024-12-26 | 2024-12-23+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $12.10 | -4,000 | 2.93M | -0.1% | -$48.4K |
| MTI | 2024-12-23 | 2024-12-19+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $10.86 | -4,000 | 2.94M | -0.1% | -$43.4K |
| MTI | 2024-12-19 | 2024-12-17+ | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Pres, Dir | S - Sale | $11.21 | -4,000 | 2.94M | -0.1% | -$44.9K |
Purchase Sale Sale after option exercise All abbreviations